Finding Cures Starts Here


The Lymphoma Research Foundation (LRF) is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma.  LRF’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.

null

Scientific Advisory Board

The LRF Scientific Advisory Board (SAB) is comprised of 45 world-renowned lymphoma experts, who seek out the most innovative and promising lymphoma research projects to support.

null

Research Programs

LRF remains dedicated to finding cures for lymphoma through an aggressively-funded program for researchers.

null

Lymphoma Consortia, Initiatives & Scientific Workshops

LRF global lymphoma consortia, research initiatives, and scientific workshops help to mobilize the research community, overcome systemic challenges and speed the progress by which new treatments are developed.

Investing in the Best and Brightest Researchers, Achieving Breakthroughs

LRF funds the very best science that has the greatest potential to impact patients and ensures the best and brightest researchers remain in the field.
To date, LRF has funded nearly $65 million in lymphoma-specific research and has supported key breakthroughs including:

  • First In-Human Clinical Trial of Adoptive Immunotherapy in Follicular Lymphoma

  • First Publication of the Whole-Genome Sequencing of Mantle Cell Lymphoma

  • Identifying the Role RNA Splicing Plays in Chronic Lymphocytic Leukemia

  • Using Micro RNA Array to Identify Biomarkers that Play a Critical Role in Mantle Cell Lymphoma Drug Resistance and Progression

  • Identifying the Mechanism Behind Ibrutinib Resistance in Mantle Cell Lymphoma

“LRF had a profound impact at the beginning of my academic career, when I needed the support most. I will always be grateful to LRF for its continuous investment in supporting innovative science, clinical research and educational programs.” – Dr. Eduardo Sotomayor, LRF Scientific Advisory Board Member

Meet Our 2020 Researchers

Pamela Allen, MD
Emory University/Winship Cancer Institute
LRF Scholar

Xu Cao, PhD
City of Hope and Beckman Research Institute
Postdoctoral Fellowship Grant

Jamie Flerlage, MD
St. Jude Children’s Research Hospital, Inc.
Stephanie A. Gregory, MD, FACP Distinguished LRF Scholar

Natalie Grover, MD
University of North Carolina at Chapel Hill
Career Development Award

Boyu Hu, MD
University of Utah/Huntsman Cancer Institute
LRF Scholar

Christina Lee, MD
Weill Cornell Medical College
LRF Scholar

Yong Gu Lee, PhD
The Trustees of the University of Pennsylvania
Postdoctoral Fellowship Grant

Adam Lin, MD, PhD
Northwestern University Feinberg School of Medicine
Postdoctoral Fellowship Grant

Ryan Lynch, MD
University of Washington
Career Development Award

Alexia Martinez de Paz, PhD
Joan & Sanford I. Weill Medical College of Cornell University
Postdoctoral Fellowship Grant

Laurianne Scourzic, PhD
Joan & Sanford I. Weill Medical College of Cornell University
Postdoctoral Fellowship Grant

Raphael Eric Steiner, MD
University of Texas MD Anderson Cancer Center
LRF Scholar

Paolo Strati, MD
University of Texas MD Anderson Cancer Center
Career Development Award

Christopher Strouse, MD
The University of Iowa
LRF Scholar

Abi Vijenthira, MD
University Health Network
LRF Scholar

FINDING CURES STARTS HERE
25 Years of Innovation & Progress

1995 was a significant year for the Lymphoma Research Foundation (LRF)—it was then that LRF realized its dual mission to eradicate lymphoma and to serve those touched by this disease.

Finding cures starts here.  Through lymphoma-specific research grants and consortia, LRF-supported researchers have been involved in many of the most significant lymphoma breakthroughs witnessed in the past quarter-century.

RESEARCH NEWS | View all >